3,793
Views
4
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Evolving measles status and immunization policy development in six European countries

ORCID Icon, ORCID Icon, & ORCID Icon
Article: 2031776 | Received 29 Oct 2021, Accepted 11 Jan 2022, Published online: 18 Feb 2022

Figures & data

Figure 1. Flow diagram for study selection.

Figure 1. Flow diagram for study selection.

Figure 2. Measles case numbers and vaccine coverage for first and second MCV dose in selected countries 2001–2019.

Case numbers as reported by the WHO for 2001–2019, supplemented by individual WHO-EU measles and rubella elimination country profiles.Citation16–21 Vaccine coverage represents official country estimates for 2001–2019 as reported by the WHO.Citation16 The red line indicates 95% coverage in the age-eligible target populations.
Figure 2. Measles case numbers and vaccine coverage for first and second MCV dose in selected countries 2001–2019.

Figure 3. Current measles vaccination schedule in selected countries.

Scheduled vaccinations as reported by ECDC and other sources.Citation21–23Cross-hatch indicates mandatory catch-up recommendation for Germany. MCV, measles-containing vaccine; MCV1, first dose of measles-containing vaccine; MCV2, second dose of measles-containing vaccine; MMR, measles-mumps-rubella-vaccine; MMRV, measles-mumps-rubella-varicella vaccine.
Figure 3. Current measles vaccination schedule in selected countries.

Table 1. Framework analysis across countries

Figure 4. Emergent themes.

Figure 4. Emergent themes.

Table 2. Key themes from semi-structured interviews

Supplemental material

Supplemental Material

Download MS Word (29.6 KB)